FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:791-797 March 19, 1998 Number 12 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Critically ill patients who require mechanical ventilation are at increased risk for gastrointestinal bleeding from stress ulcers. There are conflicting data on the effect of histamine H₂-receptor antagonists and the cytoprotective agent sucralfate on rates of gastrointestinal bleeding, ventilator-associated pneumonia, and mortality.

Methods In a multicenter, randomized, blinded, placebo-controlled trial, we compared sucralfate with the H₂-receptor antagonist ranitidine for the prevention of upper gastrointestinal bleeding in 1200 patients who required mechanical ventilation. Patients received either nasogastric sucralfate suspension (1 g every six hours) and an intravenous placebo or intravenous ranitidine (50 mg every eight hours) and a nasogastric placebo.

Results The patients in the two groups had similar base-line characteristics. Clinically important gastrointestinal bleeding developed in 10 of 596 (1.7 percent) of the patients receiving ranitidine, as compared with 23 of 604 (3.8 percent) of those receiving sucralfate (relative risk, 0.44; 95 percent confidence interval, 0.21 to 0.92; P = 0.02). In the ranitidine group, 114 of 596 patients (19.1 percent) had ventilator-associated pneumonia, as compared with 98 of 604 (16.2 percent) in the sucralfate group (relative risk, 1.18; 95 percent confidence interval, 0.92 to 1.51; P = 0.19). There was no significant difference between the groups in mortality in the intensive care unit (ICU) (23.5 percent in the ranitidine group and 22.8 percent in the sucralfate group) or the duration of the stay in the ICU (median, nine days in both groups).

Conclusions Among critically ill patients requiring mechanical ventilation, those receiving ranitidine had a significantly lower rate of clinically important gastrointestinal bleeding than those treated with sucralfate. There were no significant differences in the rates of ventilator-associated pneumonia, the duration of the stay in the ICU, or mortality.

Source Information

From McMaster University, Hamilton, Ont. (D.C., G.G., H.F., L.G., A.M.); the University of Toronto, Toronto (J.M.); the University of Western Ontario, London (D.L., F.R., A.K.); Dalhousie University, Halifax, N.S. (R.H.); Memorial University, St. John's, Newf. (S.P.); and Queen's University, Kingston, Ont. (G.W.) — all in Canada. Other authors were Martin Tweeddale, M.D., University of British Columbia, Vancouver; Joe Pagliarello, M.D., University of Ottawa, Ottawa, Ont.; and Richard Johnston, M.D., University of Alberta, Edmonton.

Address reprint requests to Dr. Cook at the Department of Medicine, St. Joseph's Hospital, 50 Charlton Ave., Hamilton, ON L8N 4A6, Canada.

Full Text of this Article

Related Letters:

Prevention of Gastrointestinal Bleeding during Mechanical Ventilation
Mitchell I., Bihari D., Wyncoll D. L.A., Marik P., Varon J., Offenstadt G., Guidet B., Maury E., Cook D., Guyatt G., Leasa D., The Canadian Critical Care Trials Group
Extract | Full Text  
N Engl J Med 1998; 339:266-268, Jul 23, 1998. Correspondence

This article has been cited by other articles:

• Kollef, M. H., Afessa, B., Anzueto, A., Veremakis, C., Kerr, K. M., Margolis, B. D., Craven, D. E., Roberts, P. R., Arroliga, A. C., Hubmayr, R. D., Restrepo, M. I., Auger, W. R., Schinner, R., for the NASCENT Investigation Group, (2008). Silver-Coated Endotracheal Tubes and Incidence of Ventilator-Associated Pneumonia: The NASCENT Randomized Trial. JAMA 300: 805-813 [Abstract] [Full Text]  
• Masterton, R. G., Galloway, A., French, G., Street, M., Armstrong, J., Brown, E., Cleverley, J., Dilworth, P., Fry, C., Gascoigne, A. D., Knox, A., Nathwani, D., Spencer, R., Wilcox, M. (2008). Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 62: 5-34 [Abstract] [Full Text]  
• Crowley, S. T., Chertow, G. M., Vitale, J., O'Connor, T., Zhang, J., Schein, R. M.H., Choudhury, D., Finkel, K., Vijayan, A., Paganini, E., Palevsky, P. M., for the VA/NIH Acute Renal Failure Trial Network S, (2008). Lessons for Successful Study Enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. CJASN 3: 955-961 [Abstract] [Full Text]  
• Zeigler, A. J, McAllen, K. J, Slot, M. G, Barletta, J. F (2008). Medication Reconciliation Effect on Prolonged Inpatient Stress Ulcer Prophylaxis. The Annals of Pharmacotherapy 42: 940-946 [Abstract] [Full Text]  
• Yarham, S., Young, P. (2008). Ventilator-associated pneumonia and new airway technologies. Trauma 10: 71-83 [Abstract]  
• Ojiako, K., Shingala, H., Schorr, C., Gerber, D. R. (2008). Famotidine Versus Pantoprazole for Preventing Bleeding in the Upper Gastrointestinal Tract of Critically Ill Patients Receiving Mechanical Ventilation. Am J Crit Care 17: 142-147 [Abstract] [Full Text]  
• Lorente, L., Blot, S., Rello, J. (2007). Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J 30: 1193-1207 [Abstract] [Full Text]  
• Wohlt, P. D, Hansen, L. A, Fish, J. T (2007). Inappropriate Continuation of Stress Ulcer Prophylactic Therapy After Discharge. The Annals of Pharmacotherapy 41: 1611-1616 [Abstract] [Full Text]  
• Omrane, R., Eid, J., Perreault, M. M, Yazbeck, H., Berbiche, D., Gursahaney, A., Moride, Y. (2007). Impact of a Protocol for Prevention of Ventilator-Associated Pneumonia. The Annals of Pharmacotherapy 41: 1390-1396 [Abstract] [Full Text]  
• Augustyn, B. (2007). Ventilator-Associated Pneumonia: Risk Factors and Prevention. Crit Care Nurse 27: 32-39 [Full Text]  
• Russo, T. A., Wang, Z., Davidson, B. A., Genagon, S. A., Beanan, J. M., Olson, R., Holm, B. A., Knight, P. R. 3rd, Chess, P. R., Notter, R. H. (2007). Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L632-L643 [Abstract] [Full Text]  
• Russell, J. A. (2006). Management of Sepsis. NEJM 355: 1699-1713 [Full Text]  
• Koenig, S. M., Truwit, J. D. (2006). Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clin. Microbiol. Rev. 19: 637-657 [Abstract] [Full Text]  
• Davis, K. A. (2006). Ventilator-associated pneumonia: a review.. J Intensive Care Med 21: 211-226 [Abstract]  
• Thalmann, M, Sodeck, G H, Kavouras, S, Matalas, A, Skenderi, K, Yannikouris, N, Domanovits, H, Rao, A, Simons, S, Yazaki, E (2006). Proton pump inhibition prevents gastrointestinal bleeding in ultramarathon runners: a randomised, double blinded, placebo controlled study * Commentary * Commentary * Commentary.. Br. J. Sports. Med. 40: 359-362 [Abstract] [Full Text]  
• Hunter, J D (2006). Ventilator associated pneumonia.. Postgrad. Med. J. 82: 172-178 [Abstract] [Full Text]  
• Spirt, M. J., Stanley, S. (2006). Update on Stress Ulcer Prophylaxis in Critically Ill Patients. Crit Care Nurse 26: 18-28 [Full Text]  
• Manlucu, J., Tonelli, M., Ray, J. G., Papaioannou, A., Youssef, G., Thiessen-Philbrook, H. R., Holbrook, A., Garg, A. X. (2005). Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrol Dial Transplant 20: 2376-2384 [Abstract] [Full Text]  
• Devlin, J. W, Welage, L. S, Olsen, K. M (2005). Proton Pump Inhibitor Formulary Considerations in the Acutely Ill Part 2: Clinical Efficacy, Safety, and Economics. The Annals of Pharmacotherapy 39: 1844-1851 [Abstract] [Full Text]  
• McClave, S. A., Chang, W.-K. (2005). When to Feed the Patient With Gastrointestinal Bleeding. Nutr Clin Pract 20: 544-550 [Abstract] [Full Text]  
• Quigley, E M M (2005). Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient. Gut 54: 1351-1352 [Full Text]  
• Russo, T. A., Davidson, B. A., Genagon, S. A., Warholic, N. M., MacDonald, U., Pawlicki, P. D., Beanan, J. M., Olson, R., Holm, B. A., Knight, P. R III (2005). E. coli virulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L207-L216 [Abstract] [Full Text]  
• Penner, R. M., Brindley, P. G., Jacka, M. J. (2005). Best evidence in critical care medicine: Stress ulcer prophylaxis in the intensive care unit: damned if you do, damned if you don't. Canadian J. Anesthesia 52: 650-651 [Full Text]  
• Martindale, R. G. (2005). Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm 62: S11-S17 [Abstract] [Full Text]  
• Coursol, C. J, Sanzari, S. E (2005). Impact of Stress Ulcer Prophylaxis Algorithm Study. The Annals of Pharmacotherapy 39: 810-816 [Abstract] [Full Text]  
• Mohr, J., Peninger, M., Ostrosky-Zeichner, L. (2005). Infection Control in Intensive Care Units. Journal of Pharmacy Practice 18: 84-90 [Abstract]  
• Devlin, J. W., Barletta, J. F. (2005). Albumin for fluid resuscitation: Implications of the Saline Versus Albumin Fluid Evaluation. Am J Health Syst Pharm 62: 637-642 [Full Text]  
• Zygun, D. A., Laupland, K. B., Fick, G. H., Sandham, J. D., Doig, C. J. (2005). Limited ability of SOFA and MOD scores to discriminate outcome: a prospective evaluation in 1,436 patients: [Limites de la capacite discriminatoire des scores de SOFA et de DMV : une evaluation prospective chez 1 436 patients]. Canadian J. Anesthesia 52: 302-308 [Abstract] [Full Text]  
• Bell, D. D., Brindley, P. G., Forrest, D., Muslim, O. A., Zygun, D. (2005). Management following resuscitation from cardiac arrest: recommendations from the 2003 Rocky Mountain Critical Care Conference: [Conduite a tenir apres la reanimation post-arret cardiaque : recommendations de la conference du Rocky Mountain Critical Care 2003]. Canadian J. Anesthesia 52: 309-322 [Abstract] [Full Text]  
• Levy, M. M., Baylor, M. S., Bernard, G. R., Fowler, R., Franks, T. J., Hayden, F. G., Helfand, R., Lapinsky, S. E., Martin, T. R., Niederman, M. S., Rubenfeld, G. D., Slutsky, A. S., Stewart, T. E., Styrt, B. A., Thompson, B. T., Harabin, A. L. (2005). Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome. Am. J. Respir. Crit. Care Med. 171: 518-526 [Abstract] [Full Text]  
• (2005). Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am. J. Respir. Crit. Care Med. 171: 388-416 [Full Text]  
• Voils, S. A., Kim, K. S., Wittbrodt, E. T. (2005). Recent Trends in the Management of Ventilator-Associated Pneumonia. Journal of Pharmacy Practice 18: 53-62 [Abstract]  
• Gregor, J. C. (2004). Acid Suppression and Pneumonia: A Clinical Indication for Rational Prescribing. JAMA 292: 2012-2013 [Full Text]  
• Weissman, C. (2004). Pulmonary Complications After Cardiac Surgery. SEMIN CARDIOTHORAC VASC ANESTH 8: 185-211 [Abstract]  
• Russo, T. A., Davidson, B. A., Topolnycky, D. M., Olson, R., Morrill, S. A., Knight, P. R. III, Murphy, P. M. (2003). Human Neutrophil Chemotaxis Is Modulated by Capsule and O Antigen from an Extraintestinal Pathogenic Escherichia coli Strain. Infect. Immun. 71: 6435-6445 [Abstract] [Full Text]  
• Collard, H. R., Saint, S., Matthay, M. A. (2003). Prevention of Ventilator-Associated Pneumonia: An Evidence-Based Systematic Review. ANN INTERN MED 138: 494-501 [Abstract] [Full Text]  
• Adhikari, N., Sibbald, W. (2003). The Large Cost of Critical Care: Realities and Challenges. Anesth. Analg. 96: 311-314 [Full Text]  
• Bryan-Brown, C. W., Dracup, K. (2003). Dying By Irreconcilable Numbers. Am J Crit Care 12: 6-8 [Full Text]  
• Salenger, R., Gammie, J. S., Vander Salm, T. J. (2003). Postoperative Care of Cardiac Surgical Patients. Card Surg Adult 2: 439-469 [Full Text]  
• Chastre, J., Fagon, J.-Y. (2002). Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med. 165: 867-903 [Abstract] [Full Text]  
• Hebert, P. C., Cook, D. J., Wells, G., Marshall, J. (2002). The Design of Randomized Clinical Trials in Critically Ill Patients*. Chest 121: 1290-1300 [Abstract] [Full Text]  
• Eggimann, P., Pittet, D. (2001). Infection Control in the ICU. Chest 120: 2059-2093 [Abstract] [Full Text]  
• BERGMANS, D. C. J. J., BONTEN, M. J. M., GAILLARD, C. A., PALING, J. C., van der GEEST, S., van TIEL, F. H., BEYSENS, A. J., de LEEUW, P. W., STOBBERINGH, E. E. (2001). Prevention of Ventilator-associated Pneumonia by Oral Decontamination . A Prospective, Randomized, Double-blind, Placebo-controlled Study. Am. J. Respir. Crit. Care Med. 164: 382-388 [Abstract] [Full Text]  
• Members of the Task Force:, , Bouza, E., Brun-Buisson, C., Chastre, J., Ewig, S., Fagon, J-Y., Marquette, C.H., Munoz, P., Niederman, M.S., Papazian, L., Rello, J., Rouby, J-J., Van Saene, H., Welte, T. (2001). Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet. Eur Respir J 17: 1034-1045 [Full Text]  
• Mutlu, G. M., Mutlu, E. A., Factor, P. (2001). GI Complications in Patients Receiving Mechanical Ventilation. Chest 119: 1222-1241 [Abstract] [Full Text]  
• Lynch, J. P. III (2001). Hospital-Acquired Pneumonia : Risk Factors, Microbiology, and Treatment. Chest 119: 373S-384S [Abstract] [Full Text]  
• Shorr, A. F., O'Malley, P. G. (2001). Continuous Subglottic Suctioning for the Prevention of Ventilator-Associated Pneumonia : Potential Economic Implications. Chest 119: 228-235 [Abstract] [Full Text]  
• Messori, A, Trippoli, S, Vaiani, M, Gorini, M, Corrado, A (2000). Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 321: 1103-1103 [Abstract] [Full Text]  
• Bonten, M. J. M., Kullberg, B. J., van Dalen, R., Girbes, A. R. J., Hoepelman, I. M., Hustinx, W., van der Meer, J. W. M., Speelman, P., Stobberingh, E. E., Verbrugh, H. A., Verhoef, J., Zwaveling, J. H. (2000). Selective digestive decontamination in patients in intensive care. J Antimicrob Chemother 46: 351-362 [Abstract] [Full Text]  
• Farrar, J J, Yen, L M, Cook, T, Fairweather, N, Binh, N, Parry, J, Parry, C M (2000). NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Tetanus. J. Neurol. Neurosurg. Psychiatry 69: 292-301 [Full Text]  
• Morehead, R. S., Pinto, S. J. (2000). Ventilator-Associated Pneumonia. Arch Intern Med 160: 1926-1936 [Abstract] [Full Text]  
• Pardi, D. S. (2000). Optimal Acid Suppression Therapy in Critically Ill Patients. ANN INTERN MED 132: 923-924 [Full Text]  
• MARKOWICZ, P., WOLFF, M., DJEDAÏNI, K., COHEN, Y., CHASTRE, J., DELCLAUX, C., MERRER, J., HERMAN, B., VEBER, B., FONTAINE, A., DREYFUSS, D., the ARDS Study Group, (2000). Multicenter Prospective Study of Ventilator-Associated Pneumonia During Acute Respiratory Distress Syndrome . Incidence, Prognosis, and Risk Factors. Am. J. Respir. Crit. Care Med. 161: 1942-1948 [Abstract] [Full Text]  
• Russo, T. A., Davidson, B. A., Priore, R. L., Carlino, U. B., Helinski, J. D., Knight, P. R III (2000). Capsular Polysaccharide and O-Specific Antigen Divergently Modulate Pulmonary Neutrophil Influx in an Escherichia coli Model of Gram-Negative Pneumonitis in Rats. Infect. Immun. 68: 2854-2862 [Abstract] [Full Text]  
• Blot, S., Vandewoude, K., Hoste, E., Colardyn, F. (2000). Tracheal Colonization in Pneumonia. Chest 117: 1216-1216 [Full Text]  
• Brundage, S. I, Maier, R. V (2000). Trauma intensive care. Trauma 2: 19-31 [Abstract]  
• Kramer, B. (1999). Ventilator-Associated Pneumonia in Critically Ill Patients. ANN INTERN MED 130: 1027-1028 [Full Text]  
• Vincent, J.-L. (1999). Prevention of nosocomial bacterial pneumonia. Thorax 54: 544-549 [Full Text]  
• Heyland, D. K., Cook, D. J., Marshall, J., Heule, M., Guslits, B., Lang, J., Jaeschke, R. (1999). The Clinical Utility of Invasive Diagnostic Techniques in the Setting of Ventilator-Associated Pneumonia. Chest 115: 1076-1084 [Abstract] [Full Text]  
• HEYLAND, D. K., COOK, D. J., GRIFFITH, L., KEENAN, S. P., BRUN-BUISSON, C. (1999). The Attributable Morbidity and Mortality of Ventilator-Associated Pneumonia in the Critically Ill Patient. Am. J. Respir. Crit. Care Med. 159: 1249-1256 [Abstract] [Full Text]  
• Kollef, M. H. (1999). The Prevention of Ventilator-Associated Pneumonia. NEJM 340: 627-634 [Full Text]  
• Nathens, A. B., Marshall, J. C. (1999). Selective Decontamination of the Digestive Tract in Surgical Patients: A Systematic Review of the Evidence. Arch Surg 134: 170-176 [Abstract] [Full Text]  
• Marik, P. E. (1999). Analytic Reviews : Stress Ulcer Prophylaxis: A Practical Approach. J Intensive Care Med 14: 1-8  
• GEORGE, D. L., FALK, P. S., WUNDERINK, R. G., LEEPER, K. V. Jr., MEDURI, G. U., STEERE, E. L., CORBETT, C. E., GLEN MAYHALL, C. (1998). Epidemiology of Ventilator-acquired Pneumonia Based on Protected Bronchoscopic Sampling. Am. J. Respir. Crit. Care Med. 158: 1839-1847 [Abstract] [Full Text]  
• Mitchell, I., Bihari, D., Wyncoll, D. L.A., Marik, P., Varon, J., Offenstadt, G., Guidet, B., Maury, E., Cook, D., Guyatt, G., Leasa, D., The Canadian Critical Care Trials Group, (1998). Prevention of Gastrointestinal Bleeding during Mechanical Ventilation. NEJM 339: 266-268 [Full Text]  
• (1998). Ranitidine vs. Sucralfate to Prevent GI Bleeding in the ICU. JWatch General 1998: 3-3 [Full Text]